In the wake of the reports of the Women’s Health Initiative and the Heart and Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that combination hormone therapy was associated ...
The pharmaceutical grade P-toluenesulfonic acid market is poised for a decade of steady expansion. Valued at USD 129.8 million in 2025, the market is forecast to reach USD 213.5 million by 2035, ...